Rennova Health, Inc. (RNVA) financial statements (2020 and earlier)

Company profile

Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800
WEST PALM BEACH, FL 33401
State of Incorp. DE
Fiscal Year End December 31
SIC 8734 - Testing Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 0 098
Cash and cash equivalents 0 098
Receivables 433110
Inventory, net of allowances, customer advances and progress billings 00   
Inventory 00   
Assets held-for-sale, not part of disposal group 00  
Other undisclosed current assets 00010
Total current assets: 533218
Noncurrent Assets
Property, plant and equipment 93370
Long-term investments and receivables     0
Long-term investments     0
Intangible assets, net (including goodwill) 0   1
Goodwill     1
Intangible assets, net (excluding goodwill) 0   1
Disposal group, including discontinued operation, noncurrent assets 00   
Other undisclosed noncurrent assets 0000 
Total noncurrent assets: 93372
TOTAL ASSETS: 1466289
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 20118101
Accounts payable 8434 
Accrued liabilities 11545 
Taxes payable 121  
Other undisclosed accounts payable and accrued liabilities     1
Debt 1321120
Derivative instruments and hedges, liabilities 0    
Due to related parties 1105 
Disposal group, including discontinued operation 22   
Deferred revenue and credits   0
Other undisclosed current liabilities 89   
Total current liabilities: 442520161
Noncurrent Liabilities
Long-term debt and lease obligation  4250
Long-term debt, excluding current maturities  4 30
Capital lease obligations  22 
Liabilities, other than long-term debt  12070
Deferred tax liabilities, net    0
Other liabilities     0
Derivative instruments and hedges, liabilities  1207 
Other undisclosed noncurrent liabilities 0 (0)  
Total noncurrent liabilities: 0162131
Total liabilities: 444121291
Temporary equity, carrying amount  6   
Stockholders' equity
Stockholders' equity attributable to parent, including: (39)(41)(15)(1)8
Common stock 00000
Additional paid in capital 3761284627141
Accumulated deficit (415)(169)(61)(28)(133)
Other undisclosed stockholders' equity attributable to parent 0000 
Other undisclosed stockholders' equity 9    
Total stockholders' equity: (30)(41)(15)(1)8
TOTAL LIABILITIES AND EQUITY: 1466289

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Revenues 150000
Revenue, net   0
Other income 1000
Cost of revenue (12)(1)(2)(9)(0)
Cost of goods and services sold (12)(1)(2)(9) 
Gross profit: 3(1)(2)(9)0
Operating expenses (28)(21)(38)(64)(6)
Other undisclosed operating income 126728 
Operating loss: (13)(16)(32)(45)(5)
Nonoperating income (expense) 0(38)(1)0(0)
Other nonoperating income (expense) 0(34)(1)0 
Interest and debt expense (22)(9)0(3) 
Loss from continuing operations before income taxes: (34)(63)(33)(48)(5)
Income tax expense (benefit) (1)(1)190
Loss from continuing operations: (35)(64)(33)(39)(5)
Loss from discontinued operations  (4)   
Loss before gain (loss) on sale of properties: (35)(68)(33)(39)(5)
Other undisclosed net income (loss)   (0)3 
Net loss: (35)(68)(33)(36)(5)
Other undisclosed net income (loss) attributable to parent 2113 (2) 
Net loss attributable to parent: (14)(55)(33)(38)(5)
Other undisclosed net loss available to common stockholders, basic (232)(53)   
Net loss available to common stockholders, diluted: (246)(109)(33)(38)(5)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Net loss: (35)(68)(33)(36)(5)
Comprehensive loss, net of tax, attributable to parent: (35)(68)(33)(36)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: